Montreal, Quebec, Canada
Director of The Neuro's Early Drug Discovery Unit, partnering with researchers, companies and patient foundations on their "First Steps' towards translating a target into a therapy across CNS disorders. Reach out if we can help you on this journey. (https://www.mcgill.ca/neuro/open-science/open-science-platforms/eddu). To learn more about our work, check out our latest publications in our resource hub (https://www.neuro-edduportal.com/).
Director of The Neuro's Early Drug Discovery Unit, partnering with researchers, companies and patient foundations on their "First Steps' towards translating a target into a therapy across CNS disorders. Reach out if we can help you on this journey. (https://www.mcgill.ca/neuro/open-science/open-science-platforms/eddu). To learn more about our work, check out our latest publications in our resource hub (https://www.neuro-edduportal.com/).
As associate director of the Early Drug Discovery Unit (EDDU) at the The Neuro, I oversaw the growth and expansion of the team to 40+ research staff and trainees, managing multiple projects with distinct milestones and deliverables all focused on discovery and translational applications of human stem cells.
Advancing our understanding into disorders of the brain with stem cell models.
Working alongside Dr. Alison Axtman, we are developing a research topic with unique contributions on "The next generation of tools and technologies for studying human neurons in a dish". Contributions are still welcome, and details are available at this link. https://www.frontiersin.org/research-topics/17187/the-next-generation-of-tools-and-technologies-for-studying-human-neurons-in-a-dish
In my previous position as an assistant professor at The Neuro and McGill University, my focus was on the cell Biology of Parkinson's disease group and other neurodegenerative disorders, focused on the use of induced pluripotent stem cells and CRISPR technology as tools to understand why these disorders develop.
My research focused on understanding the function of parkin, a Parkinson's disease associated protein,and its interactions with deubiquitinating enzymes, in the context of neurodegenerative disease. I am trained in a variety of cell-based and in vitro assays, in addition to immunofluorescence microscopy.